FDA Approves Blood-Based Prostate Cancer Test
The test receives premarket approval as an aid in biopsy decision-making for men 50 and older with elevated PSA levels.
Read More
Search Results for: prostate cancer
MyOme Launches Integrated Polygenic Risk Score for Prostate Cancer
The whole-genome test combines data from 7 million genetic markers with clinical risk factors to provide individualized 10-year and lifetime risk assessments.
Read More
Mercy Offers New Hereditary Cancer Testing for High-Risk Patients
A screening tool aims to identify patients at high risk for cancer who may benefit from germline or hereditary DNA testing.
Read More
PSA Screening Shows Sustained Prostate Cancer Mortality Reduction in 23-Year Study
Research demonstrates 13% relative reduction in prostate cancer deaths but highlights overdiagnosis concerns, prompting calls for risk-based screening approaches.
Read More
Breaking Down Barriers to Cervical Cancer Screening Compliance by Introducing Self-Collection
Self-collection for HPV and other infections offers a more convenient, private way to complete recommended screenings—helping reach women who might otherwise delay or skip care.
Read More